DIREVO announces transfer of patents from Evotec
11-Jul-2008
"This is a very important milestone for the company, because DIREVO now owns essential parts of intellectual property protecting its technology" said Dr. Thomas von Rüden, CEO of DIREVO. "This will give us much greater flexibility in the company's future corporate development, e.g., it will allow us to spin out legal entities able to focus and further develop and customize the technology in their own markets"
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.